-
51m 36sPart 2 | Session 2 Session 2.1: Coronary Calcifications Updates
-
1h 5m 33sPart 2 | Session 3 Session 2.2: Live Cases & Discussions
-
58m 49sPart 2 | Session 4 Session 2.3: Imaging Focus
-
1h 5m 56sPart 2 | Session 5 Session 2.4: Live Cases & Discussions
-
3m 57sPart 2 | Session 6 Day Two Close
-
2mPart 3 | Session 1 Day Welcome: Debates & Controversies
-
1h 1m 13sPart 3 | Session 2 Session 3.1: Keynote & Debates
-
55m 15sPart 3 | Session 3 Session 3.2: Live Cases & Discussions
-
59m 46sPart 3 | Session 4 Session 3.3: Controversies
-
4m 16sPart 3 | Session 5 Day Three Close
-
3m 36sPart 1 | Session 1 Day Welcome: Structural Heart Disease
-
59m 1s
-
59m 33sPart 1 | Session 3 Session 1.2 Live Cases & Discussions
-
39m 31sPart 1 | Session 4 Session 1.3: Revalving for Transcatheter Heart Valve Failure
-
50m 48sPart 1 | Session 5 Session 1.4: Live Cases & Discussions
-
1m 46sPart 1 | Session 6 Day One Close
TIO 2024 brought together an outstanding international faculty, creating an unparalleled interactive experience that will keep the global interventional cardiology community up-to-date with the latest advancements in transcatheter treatment strategies. Featuring a combination of expert opinions, engaging discussions, insightful presentations and live cases from prominent medical centres on both sides of the Atlantic, TIO delivered the highest-quality CME-accredited education.
Related Content:
Key Learning Objectives
- Review planning and valve selection strategies in patients with prior valve failure
- Summarise recent repair and replacement data in mitral and tricuspid regurgitation
- Select suitable tools for undertaking PCI in calcified lesions
- Optimise use of imaging in daily practice
- Outline the pros and cons of using P2Y12 inhibitors universally following PCI
- Identify situations where an IVUS or OCT-guided approach are preferable
- Discuss the possible implications of TAVR becoming a care option in asymptomatic aortic stenosis
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2
Day Two: Complex PCI
Part 3
Day Three: Debates & Controversies
Faculty Biographies
Ajay J Kirtane
Professor of Clinical Medicine
Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.
In addition to his clinical commitments, Ajay has a strong interest in clinical education and research, serving as Chief Academic Officer of Columbia Interventional Cardiovascular Care. He is a director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Ajay’s research…
Comments